RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00035024.xml
PDF herunterladen
Thromb Haemost 1977; 38(04): 0751-0775
DOI: 10.1055/s-0038-1651896
DOI: 10.1055/s-0038-1651896
Original Article
Participation of Hageman Factor Dependent Pathways in Human Disease States
Weitere Informationen
Publikationsverlauf
Publikationsdatum:
04. Juli 2018 (online)
Summary
Abnormalities of Hageman factor dependent pathways have been described in a wide variety of human disease states. Congenital deficiencies of factor XII (Hageman trait) prekallikrein (Fletcher trait) and high molecular weight kininogen (Williams, Fitzgerald and Flaujeac traits) although resulting in profound in vitro changes, do not cause in vivo difficulties. In contrast, deficiency of Cl esterase inhibitor (hereditary angioedema) results in significant morbidity and mortality. Acquired diseases may exhibit decreased synthesis of these three proteins in cirrhosis and dengue fever. In vivo activation of factor XII initiated pathways occur in septic shock, disseminated or localized intravascular coagulation, typhoid fever, polycythemia vera, hyperbetalipoproteinemia, coronary artery disease, nephrotic syndrome, transfusion reactions, hemodialysis and extracorporeal bypass. Activation of both the intrinsic system and tissue mediators contribute to the vasomotor phenomena in carcinoid syndrome and postgastrectomy dumping. Roles for factor XII, prekallikrein and kininogen have been suggested in gouty arthritis, allergic disorders and cystic fibrosis but the evidence is not yet convincing in these disorders.
-
References
- 1 Austen K. F, Sheffer A. L. 1965; Detection of hereditary angioneurotic edema by demonstration of reduction of second component of complement. New England Journal of Medicine 272: 649.
- 2 Bagdasarian A, Talamo R. C, Colman R. W. 1973; a Isolation of high molecular weight activators of prekallikrein. Journal of Biological Chemistry 248: 3456.
- 3 Bagdasarian A, Lahiri B, Colman R. W. 1973; b Origin of the high molecular weight activator of prekallikrein. Journal of Biological Chemistry 248: 1142.
- 4 Bagdasarian A, Lahiri B, Talamo R. C, Wong P. Y, Colman R. W. 1974; Immunochemical studies of plasma kallikrein. Journal of Clinical Investigation 54: 1444.
- 5 Bell G. 1965; Peripheral circulation during the dumping syndrome. British Journal of Surgery 52: 300.
- 6 Blümel G, Klauser G, Neumayr A, Peschl L, Rottenbacker-Teubner H. 1967; Die Bedeutung der Plasmakinine bei der Entstehung des Dumping-Syndromes. Medizinische Welt 2751.
- 7 Bokisch V. A, Top jr. F. H, Russel P. K. 1973; The potential pathogenic role of complement in dengue hemorrhagic shock syndrome. New England Journal of Medicine 289: 996.
- 8 Bouma B. N, Griffin J. H. 1977; Human prekallikrein (plasminogenproactivator): Purification, characterization and activation by activated factor XII. Thrombosis and Haemostasis 38: 136.
- 9 Briseld K, Qvigstaid E. K, Engelstad M, Kageriov P, Lange-Nielsen F. 1976; Assay of factors of the kinin systems in plasma from patients with specific exogenous allergies. Acta Allergologica 31: 297.
- 10 Brocklehurst W. E, Zeitlin I. J. 1967; Determination of plasma kinin and kininogen levels in man. Journal of Physiology 191: 417.
- 11 Brockway W. J, Castellino F. J. 1971; The mechanism of the inhibition ofplasmin activity by E-aminocaproic add. Journal of Biological Chemistry 246: 4641.
- 12 Burrowes C. E, Movat H. V, Soltay M. J. 1971; The kinin system of human plasma VI. The action of plasmin. Proceedings of the Society of Experimental Biological Medidne 138: 959.
- 13 Busch G. J, Kobayashi K, Hollenberg N. K, Birtch A. G, Colman R. W. 1975; b Hyperacute renal allograft rejection in the primate. Intrarenal effects of heparin and associated net release of factor VIII activity and kallikrein activation. American Journal of Pathology 80: 1.
- 14 Busch G. J, Martins A. C. P, Hollenberg N. K, Wilson R. E, Colman R. W. 1975; a Aprímate model of hyperacute renal allograft rejection. American Journal of Pathology 79: 31.
- 15 Carvalheira A. F, Welsch U, Pearse A. G. E. 1968; Cytochemical and ultrastructural observations on the argentaffin and argyrophil cells of the gastrointestinal tract in mammals and their place in the APUD series of polypeptide-secreting cells. Histochemie 14: 33.
- 16 Carvalho A. C, Colman R. W, Lees R. S. 1974; a Platelet function in hyperlipoproteinemia. New England Journal of Medidne 290: 434.
- 17 Carvalho A. G, Colman R. W, Lees R. S. 1974; b Clofibrate reversal of platelet hypersensitivity in hyperlipoproteinemia. Circulation 50: 570.
- 18 Carvalho A. C, Ellman L. 1976; Activation of the coagulation system in polycythemia vera. Blood 47: 669.
- 19 Carvalho A. C, Lees R. S, Vaillancourt R. A, Cabral R. B, Weinberg R. M, Colman R. W. 1976; Intravascular coagulation in hyperlipoproteinemia. Thrombosis Research 8: 843.
- 20 Carvalho A. C, Lees R. S, Vaillancourt R. A, Colman R. W. 1977; Effect of clofibrate on intravascular coagulation in hyperlipoproteinemia. Circulation 56: 114.
- 21 Castania A, Rothschild A. M. 1974; Lowering of kininogen in rat blood by adrenalin. Inhibition by sympatholytic agents, heparin and aspirin. British Journal of Pharmacology 50: 375.
- 22 Cochrane C. G, Revak S. D, Wuepper K. D. 1973; Activation of Hageman factor in solid and fluid phases. A critical role of kallikrein. Journal of Experimental Medicine 138: 1564.
- 23 Cochrane C. G, Wuepper K. D. 1971; The first component of the kinin forming system in human and rabbit plasma. Journal of Experimental Medicine 134: 986.
- 24 Cohen S. H, Halstead S. B. 1966; Shock associated with dengue infection. I Clinical and physiologic manifestations of dengue hemorrhagic fever in Thailand 1964. Journal of Pediatrics 68: 448.
- 25 Collier H. O. J. 1966. Self-antagonism of broncho construction induced by bradykinin and angiotension. In: Erdos E. G, Back N, Sicuteri F, Wilde A. F. (eds.) Hypotensive Peptides. Springer; Berlin – Heidelberg – New York: 305.
- 26 Colman R. W. 1969; Activation of plasminogen by human plasma kallikrein. Biochemical Biophysical Research Communications 35: 273.
- 27 Colman R. W. 1976; Hereditary angioedema and heparin therapy. Annals of Internal Medicine 85: 399.
- 28 Colman R. W, Bagdasarían A, Talamo R. C, Scott C. F, Seavey M, Guimaraes J. A, Pierce J. V, Kaplan A. P. 1975; Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways. Journal of Clinical Investigation 56: 1650.
- 29 Colman R. W, Braun W. E, Busch G. J, Dammin G. J, Merrill J. P. 1969; a Coagulation studies in hyperacture and other forms of renal allogrant rejection. New England Journal of Medicine 281: 685.
- 30 Colman R. W, Girey G, Galvanek E. G, Busch G. J. 1972. Human renal allografts: The protective effects of heparin, kallikrein activation and fibrinolysis during hyperacture rejection. In: Thomas C. C. Symposium on Coagulation Problems in Transplanted Organs. Illinois: 87.
- 31 Colman R. W, Mason J. W, Sherry S. 1969; b The Kallikreinogen-kallikrein enzyme system of human plasma. Assay of components and observation in disease states. Annals of Internal Medicine 71: 763.
- 32 Colman R. W, Mattler L, Sherry S. 1969; c Studies on the prekallikrein (kallikreinogen) – kallikrein enzyme system of human plasma II. Evidence relating the kaolin-activated arginine esterase to plasma kallikrein. Journal of Clinical Investigation 48: 23.
- 33 Colman R. W, Scoh C. F, Edelman R, Gilman R. H. 1978 Plasma kallikrein activation and inhibition during typhoid fever. Journal of Clinical Investigation. (in press).
- 34 Colman R. W, Wong P. Y, Talamo R. C. 1976. Kallikrein-kinin system in carcinoid and postgastrectomy dumping syndrome. In: Pisano J. J, Austen K. F. Chemistry and Biology of the Kallikrein-Kinin System in Health and Disease. Fogarty International Center; Proceeding, No. 27 487.
- 35 Cuevas P, Fine J. 1973; Production of fatal endotoxin shock by vasoactive substances. Gastroenterology 64: 285.
- 36 Currimbhoy A, Vinciguerru V, Palakavongs P, Kuslansky P, Degnan T. J. 1976; Fletcher factor deficiency and myocardial infarction. American Journal of Clinical Pathology 65: 970.
- 37 Cuschieri A, Onabanjo O. A. 1971; Kinin release after gastric surgery. British Medical Journal 3: 565.
- 38 Delbianco P. L, Fanciullacci M, Frarchi G. 1972; Plasmatickininogen in acute hepatitis andin liver cirrhosis. Advances in Experimental Medicine and Biology 21: 453.
- 39 Doeglas H. M. G, Bleumink E. 1974; Familial cold urticaria. Archives of Dermatology 110: 382.
- 40 Doeglas H. M. G, Bleumink E. 1975; Protease inhibitors in plasma of patients with chronic urticaria. Archives of Dermatology 111: 979.
- 41 Donaldson V. H. 1968; Mechanism of activation of Cl esterase in hereditary angioedema plasma in vitro: Role of Hageman factor clot promoting agent. Journal of Experimental Medicine 127: 411.
- 42 Donaldson V. H, Evans R. R. 1963; A biochemical abnormality in hereditary angioneurotic edema. Absence of serum inhibitor of C’l esterase. American Journal of Medicine 35: 35.
- 43 Donaldson V. H, Glueck H. I, Miller M. A, Movat H. Z, Habal F. 1976; Kininogen deficiency in Fitzgerald trait: Role of high molecular weight kininogen in clotting and fibrinolysis. Journal of Laboratory and Clinical Medicine 89: 327.
- 44 Donaldson V. H, Ratnoff O. D, Dias da Silva W, Rosen F. S. 1969; Permeability-increasing activity of hereditary angioneurotic edema. II. Mechanism of formation and partial characterization. Journal of Clinical Investigation 48: 642.
- 45 Donaldson V, Rosen F. S. 1964; Action of complement in hereditary angioneurotic edema: Role of C’l esterase. Journal of Clinical Investigation 43: 2204.
- 46 Donaldson V. H, Rosen F. S, Bing D. H. 1977; Role of the second component of complement (C2) in hereditary angioneurotic edema (HANE) plasma. Clinical Research 25: 520A.
- 47 Edelman R, Nimmannitya S, Colman R. W, Talamo R. C, Top F. H. 1975; Evaluation of the plasma kinin system in dengue hemorrhagic fever. Journal of Laboratory and Clinical Medicine 86: 410.
- 48 Erdos E. G. 1969 The kallikrein-kinin-kininasë system. Cellular and human mechanisms in anaphylaxis and allergy. Edited by Movat Vasel H. Z, Karger S. 233.
- 49 Erdos E. G, Miwa I. 1968; Effect of endotoxin shock on plasma kallikrein-kinin system of the rabbit. Federation Proceedings 27: 92.
- 50 Fanciullacci M, Galli P, Monetti P, Pela I, Delbianco P. L. 1975; Prekallikrein and kallikrein inhibitor in liver cirrhosis and hepatitis. Advances in Experimental Medicine and Biology 70: 201.
- 51 Forsmann W. G, Orei L, Pictet R, Renold A. E, Roviller C. 1969; The endocrine cells in the epithelium of the gastrointestinal mucosa of the rat. Journal of Cell Biology 40: 692.
- 52 Frank M. M, Sergent J. S, Kane M. A, Alling D. W. 1972; Epsilon aminocapric add therapy of hereditary angioedema. A double blind study. New England Journal of Medicine 281: 808.
- 53 Gadek J. E, Hosea S. W, Gelford S. A, Frank M. M. 1977; Cl inhibitor phenotypes in hereditary angioedema. Genetic implications of successful Danazol therapy. Clinical Research 25: 357a.
- 54 Galletti R, Matassi L, Chiarini P, Vecchiet L, Buzzelli G, Marra N. 1968; Plasma kinin activity in cirrhotic subjects. Lo Sperimentale 118: 253.
- 55 Gigli I, Mason J. W, Colman R. W, Austen K. F. 1970; Interaction of plasma kallikrein with the Cl inhibitor. Journal of Immunology 104: 574.
- 56 Girey G. J. D, Talamo R. C, Colman R. W. 1972; The kinetics of release of bradykinin by kallikrein in normal plasma. Journal of Laboratory and Clinical Medicine 80: 465.
- 57 Gjonnaess H. 1972; a Cold promoted activation of factor VII: I Evidence for existence of an activation. Thrombosis et Diathesis Haemorrhagica 28: 155.
- 58 Gjonnaess H. 1972; b Cold promoted activation of factor VII: III Relation to the kallikrein system. Thrombosis et Diathesis Haemorrhagica 28: 182.
- 59 Glueck H. I, Roehill W. 1966; Myocardial infarction in a patient with Hageman (factor XII) defect. Annals of Internal Medicine 64: 390.
- 60 Goldsmith G. H, Stern R. C, Saito H, Ratnoff O. D. 1977; Normal plasma agrinine esterase and the Hageman factor (factor XII)-prekallikrein-kininogen system in cystic fibrosis. Journal of Laboratory and Clinical Medicine 89: 131.
- 61 Green J, Talamo R. C, Colman R. W. 1974; Kinetics of kinin release in canine plasma. American Journal of Physiology 226: 784.
- 62 Griffin J. H, Cochrane C. G. 1976; Mechanisms for the involvement of high molecular weight kininogenin surface dependent reactions of Hageman factor. Proceedings of the National Academy of Sciences 73: 2554.
- 63 Habal F. M, Movat H. Z, Burrowes C. E. 1974; Isolation of two functionally different kininogens from human plasma. Separation from proteolytic inhibitors and interaction with plasma kallikrein. Biochemistry Pharmacology 23: 2291.
- 64 Harpel P. C. 1970; Cl inactivator inhibition by plasmin. Journal of Clinical Investigation 49: 568.
- 65 Hasimoto K, Warka J, Kohn R. N, Wilkens H. J, Steger R, Back N. 1975; Thevasopeptide kinin system in acute clinical cardiac disease. Advances in Experimental Medicine and Biology 70: 245.
- 66 Hathaway W. E, Belhanson L. P, Hathaway H. S. 1965; Evidence for a new thromboplastin factor: Case report, coagulation studies and physio chemical studies. Blood 26: 521.
- 67 Hattersley P. G, Hayes D. 1970; Fletcher factor deficiency; report of three unrelated cases. British Journal of Haematology 18: 411.
- 68 Herman C. M, Oshima G, Erdos E. G. 1974; The effect of adrenocorticoid pretreatment on kinin system and coagulation response to septic shock in the baboon. Journal of Laboratory and Clinical Medicine 84: 731.
- 69 Herzheimer H, Streseman E. 1961; Effect of bradykinin aerosol in guinea pigs and man. Journal of Physiology 158: 38P.
- 70 Hirsch E. F, Nagajima T, Oshima G, Erdos E. G, Herman C. M. 1974; Kinin system responses in sepsis after trauma in man. Journal of Surgical Research 17: 147.
- 71 Hoak J. C, Swenson L. W, Warner E. D. 1966; Myocardial infarction associated with severe factor XII deficiency. Lancet II: 884.
- 72 Hollenberg N. K, Retik A. B, Rosen S. M, Murray J. E, Merrillm J. P. 1968; The role of vasoconstriction in the ischemia of renal allograft rejection. Transfusion 6: 59.
- 73 Honig G. R, Lindley A. 1971; Deficiency of Hageman factor (factor XII) in patients with the nephrotic syndrome. Journal of Pediatrics 78: 633.
- 74 Izaka K, Morichi S, Fujita Y, Hasegawa E. 1975; A kininogen-like substance in unheated human plasma proteins. Transfusion 15: 46.
- 75 Izaka K, Tsutsui E, Mina Y, Hasegawa E. 1974; A bradykinin-like substance heat treated human plasma protein solution. Transfusion 14: 242.
- 76 Johnson L. P, Jesseph J. E. 1961; Evidence for a humoral etiology of the dumping syndrome. Surgical Forum 12: 316.
- 77 Jonasson O, Becker E. L. 1966; Release of kallikrein from guinea pig lung during anaphylaxis. Journal of Experimental Medicine 123: 509.
- 78 Kallen R. J, Soo-Kwang L. 1975; A study of the plasma kinin-generating system in children with the minimal lesion, idiopathic nephrotic syndrome. Pediatric Research 9: 705.
- 79 Kaplan A. P, Austen K. F. 1970; A prealbumin activator of prekallikrein. Journal of Immunology 105: 802.
- 80 Kaplan A. P, Austen K. F. 1971; A prealbumin activator of prekallikrein II. Derivation of activators of prekallikrein from active Hageman factor by digestion with plasmin. Journal of Experimental Medicine 133: 696.
- 81 Kaplan A. P, Austen K. F. 1972; b The fibrinolytic pathway of human plasma. Isolation and characterization of the plasminogen proactivator. Journal of Experimental Medicine 136: 1378.
- 82 Katori M, Nagaoka H. 1976 Significance of the kinin system and inhibition ofkinin formation by kallikrein inhibition in extracorporeal circulation in open-heart surgery patients. In: Chemistry and Biology of the Kallikrein-Kinin System in Health and Disease. (eds.) Pisano J. L, Austen K. I. 553.
- 83 Kellermeyer R. W. 1964. Activation of Hageman factor by sodium urate crystals. Proceedings of conference on gout and purine metabolism. (ed.) Gutman A. B. New York: Grune and Stratton; 741.
- 84 Kellermeyer R. W, Breckenridge R. T. 1965; The inflammatory process in acute gouty arthritis. I. Activation of Hageman factor by sodium urate crystals. Journal of Laboratory and Clinical Medicine 65: 307.
- 85 Kellermeyer R. W, Graham R. C. 1968; Kinins-possible physiologic and pathologic roles in the man. New England Journal of Medicine 279: 859.
- 86 Kellermeyer R. W, Nagg G. B. 1975; Chemical mediators of inflammation in acute gouty arthritis. Arthritis and Rheumatism (Suppl.) 18: 765.
- 87 Klemperer M. R, Donaldson V. H, Rosen F. S. 1968; Effect of C’l esterase on vascular permeability in man. Journal of Clinical Investigation 47: 604.
- 88 Laake K, Vennerod A. M. 1974; Factor XII-induced fibrinolysis studies on the separation of prekallikrein, plasminogen proactivator and factor XI in human plasma. Thrombosis Research 4: 285.
- 89 Lacombe M. J, Varet B, Levy J. P. 1975; A hitherto underscribed plasma factor acting at the contact phase of blood coagulation (Flaujeac factor): Case report and coagulation studies. Blood 46: 761.
- 90 Lacombe N. J. 1975; Deficit constitutionel en un nouveau facteur de la coagulation intervenant au niveau de contact: le facteur “Flaujeac”. C. F. Hebd. Seances Academy of Sciences 280: 1039.
- 91 Lahiri B, Talamo R. C, Mitchell B, Bagdasarian A, Colman R. W, Rosenberg R. 1976; Antithrombin III an inhibitor of human kallikrein. Archives of Biochemistry and Biophysics 175: 737.
- 92 Landerman N. S. 1962; Hereditary angioneurotic edema. I. Case reports and review of literature. Journal of Allergy 33: 316.
- 93 Landerman N. S, Webster M. E, Becker E. L, Ratcliffe H. D. 1962; Hereditary angioneurotic edema. Journal of Allergy 33: 330.
- 94 Lange L. G, Carvalho A. C, Bagdasarian A, Lahiri B, Colman R. W. 1974; Activation of Hageman factor in the nephrotic syndrome. American Journal of Medicine 56: 565.
- 95 Lieberman J. 1974; Plasma arginine esterase activity in cystic fibrosis. American Reviews of Respiratory Diseases 109: 399.
- 96 Liu C. Y, Scott C. F, Bagdasarian A, Pierce J. V, Kaplan A. P, Colman R. W. 1977; Potentiation of the function of Hageman factor fragments by high molecular weight kininogen. Journal of Clinical Investigation 60: 7.
- 97 Lopas H, Birndorf N. I, Bell Jr. C. E, Robboy S, Colman R. W. 1973; Immune hemolytic transfusion in monkeys: Activation of the kallikrein system. American Journal of Physiology 225: 372.
- 98 Lukjan H, Hofman J, Kiersnoroska B, Bielawiec M, Chyrek-Borowska S. 1972; The kinin system in allergic states. Allergic and Immunologic Band 18: 25.
- 99 Lutcher C. L. 1976; Reid trait: A new expression of high molecular weight kininogen (HMW-Kininogen) deficiency. Clinical Research 24: 47 abstract.
- 100 MacDonald J. M, Webster Jr. M. M, Tennyson C. H, Drapanos T. 1969; Serotonin and bradykinin in the dumping syndrome. American Journal of Surgery 117: 204.
- 101 MacKay M. E, Maycock W, Silk E, Cambridge B. S. 1965; Studies on fibrinogen fractions isolated from human plasma by precipitation with cold ether I. Plasma kinin formation by the activation of contaminated plasminogen. British Journal of Haematology 11: 563.
- 102 Mandle R, Colman R. W, Kaplan A. P. 1976; Identification of prekallikrein and high molecular weight (HMW) kininogen as a circulating complex in human plasma. Proceedings of the National Academy of Sciences 73: 4179.
- 103 Mandle R, Kaplan A. P. 1977 Hageman factor substrates II. Human plasma prekallikrein: Mechanism of activation by Hageman factor and participating in Hageman factor dependent proteolysis. Journal of Biological Chemistry. in press.
- 104 Mason D. T, Melmon K. L. 1965; Effects of bradykinin on forearm venous tone and vascular resistance in man. Circulation Research 17: 106.
- 105 Mason J. W, Colman R. W. 1971; The role of Hageman factor in disseminated intravascular coagulation induced by sepsis neoplasia or liver disease. Thrombosis et Diathesis Haemorrhagica 26: 325.
- 106 Mason J. W, Kleeberg U. R, Dolan P, Colman R. W. 1970; Plasma kallikrein and Hageman factor in gram negative bacteremia. Annals of Internal Medicine 73: 545.
- 107 Matheson R. T, Miller D. R, Lacombe M. J, Han Y. N, Iwanaga S, Kato H, Wuepper K. D. 1976; Reconstitution with highly purified bovine high molecular weight-kininogen and delineation of a new permeability-enhancing peptide released by plasma kallikrein from bovine high molecular weight-kininogen. Journal of Clinical Investigation 58: 1395.
- 108 McGrath J. M, Stewart G. J. 1969; The effects of endotoxin on vascular endothelium. Journal of Experimental Medicine 129: 833.
- 109 Meier H. K, Webster M. E, Mandle R, Colman R. W, Kaplan A. P. 1977; a Enhancement of the surface dependent Hageman factor activation by high molecular weight kininogen. Journal of Clinical Investigation 60: 18.
- 110 Meier J. L, Scott C. F, Mandle Jr. R, Webster M. E, Pierce J. V, Colman R. W, Kaplan A. P. 1977; Requirements for contact activation of human Hageman factor. Annals of the New York Academy of Sciences 283: 93.
- 111 Melmon K. L, Lovenberg W, Sjoerdsma A. 1965; Characteristics of carcinoid tumor kallikrein: identification of lysyl-bradykinin as a peptide it produces in vitro. Clinical Chimica Acta 12: 292.
- 112 Melmon K. L, Webster M. E, Goldfinger S. E, Seegmiller J. E. 1967; The presence of a kinin in inflammatory synovial effusion from arthritis of varying etiology. Arthritis and Rheumatism 10: 13.
- 113 Miller R. L, Reichgott M. J, Melmon K. L. 1973; Biochemical mechanisms of generation of bradykinin by endotoxin. Journal of Infectious Diseases 125 (Suppl.) 144.
- 114 Minna J. D, Robboy S. J, Colman R. W. 1974. Disseminated intravascular coagulation in man. Thomas, C. C.; Illinois.:
- 115 Movat H. Z, Belorenzo N. L, Mustard J. F, Helmel G. 1966; Activation of Hageman factor and vascular permeability factor in serum by Ag-Ab precipitates. Federation Proceedings 25: 682.
- 116 Nies A. S, Forsyth R. P, Williams H. E, Melmon K. L. 1968; Contribution of kinin to endotoxin shock in unanesthetized Rhesus monkeys. Circulation Research 22: 155.
- 117 Oates J. A, Melmon K, Sjoerdsma A, Gillespie L, Mason D. T. 1964; Release of a kinin peptide in the carcinoid syndrome. Lancet I: 514.
- 118 Oates J. A, Pettinger W. A, Doctor R. B. 1966; Evidence for the release of bradykinin in carcinoid syndrome. Journal of Clinical Investigation 45: 173.
- 119 O’Donnell T. F, Clowes Jr. G. H, Talamo R. C, Colman R. W. 1976; Kinin activation in the blood of patients with sepsis. Surgery, Gynecology and Obstetrics 143: 539.
- 120 Paskhina T. S, Krinskaya A. V. 1974; Uprochennyimetod opredeleniia kallikreinogena i kallikreinia v syvorotke (plasme) krovi cheloveka v nosme i pri nekotorykh pathologichiecheskikh sostonianiiakh. Vopr Medicine Khim 20 (06) 660.
- 121 Pence H. L, Evon R, Guerney L. H, Gerhard R. G. 1974; Prophylactic use of epsilon aminocaproic acid for oral surgery in a patient with hereditary angioneurotic edema. Journal of Allergy and Clinical Immunology 53: 298.
- 122 Peterson D. W, Hamilton W. H, Lilyblade A. L. 1971; Hereditary susceptability to dietary induction of gout in selected lines of chickens. Journal of Nutrition 101: 347.
- 123 Phelps P, McCarty jr. D. J. 1966; Crystal-induced inflammation in canine joints II. Importance of polymorphonuclear leukocytes. Journal of Experimental Medicine 124: 115.
- 124 Phelps P, Prockop D. J, McCarty D. T. 1966; Crystal-induced inflammation in canine joints III. Evidence against bradykinin as a mediator of inflammation. Journal of Laboratory and Clinical Medicine 68: 433.
- 125 Pickering R. J, Kelly J. R, Goode R. A, Gewitz H. 1969; Replacement therapy in hereditary angioedema: Successful treatment of two patients with fresh frozen plasma. Lancet I: 326.
- 126 Pierce J. V, Guimaraes J. A. 1977. Further characterization of highly purified human plasma kininogens. In: Chemistry and Biology of the kallikrein-kinin system in Health and Disease. U.S. Government Printing Office; Washington, D.C.: 121.
- 127 Pitt B, Mason J, Conti C. R. 1969; Observations on the plasma kallikrein system during myocardial ischemia. Transactions of Association of American Physicians 82: 98.
- 128 Radcliffe R, Bagdasarían A, Colman R. W, Nemerson Y. 1977 Activation of factor VII by Hageman factor fragments. Blood. in press.
- 129 Rao G. J. S, Nadler H. L. 1973; Deficiency of trypsin-like activity in saliva of patients with cystic fibrosis. Journal of Pediatrics 80: 573.
- 130 Rao G. J. S, Nadler H. L. 1974; Arginine esterase in cystic fibrosis of the pancreas. Pediatric Research 8: 684.
- 131 Rao G. J. S, Nadler H. L. 1975; Deficiency of arginine esterase in cystic fibrosis of the pancreas: Demonstration of the proteolytic nature of the activity. Pediatric Research 9: 739.
- 132 Rao G. J. S, Posner L. A, Nadler H. L. 1972; Deficiency of kallikrein activity in plasma of patients with cystic fibrosis. Science 177: 610.
- 133 Rapaport S, Aas K, Owen P. A. 1955; Effect of glass upon the activity of various plasma clotting factors. Journal of Clinical Investigation 34: 9.
- 134 Ratnoff O. D. 1966. The biology and pathology of the initial coagulation reactions. In: Brown E. B, Moore C. V. (ed.) Progress in Hematology. 5 204 Grune and Stratton, Inc.; New York.:
- 135 Ratnoff O. D, Busce R. J, Sheon R. P. 1968; The demise of John Hageman. New England Journal of Medicine 279: 760.
- 136 Ratnoff O. D, Colopy J. E. 1955; A familial hemorrhagic trait associated with a deficiency of a clot-promoting fraction of plasma. Journal of Clinical Investigation 34: 601.
- 137 Rafnoff O. D, Davie E. W, Mallet D. L. 1961; Study on the action of Hageman factor: Evidence that activated Hageman factor in turn activates plasma thromboplastin antecedent. Journal of Clinical Investigation 40: 803.
- 138 Ratnoff O. D, Pensky J, Ogston D, Naff G. B. 1969; The inhibition of plasmin, plasma kallikrein, plasma permeability factor and the C lr subcomponent of the first component of complement by serum Cl esterase inhibitor. Journal of Experimental Medicine 129: 315.
- 139 Revak S. D, Cochrane C. G, Johnston A. R. 1973; Structure of Hageman factor in its native and activated forms. Federation Proceedings 32: 845.
- 140 Robinson J. A, Klodyncky M. L, Loeb H. S, Racic M. R, Gunnar R. M. 1975; Endotoxin, prekallikrein, complement and systemic vascular resistance. Sequential measurement in man. American Journal of Medicine 59: 61.
- 141 Rochae Silva M, Antonio A. 1960; Release of bradykinin and the mechanism of production of a “Thermic” edema (45°C) in the rat’s paw. Medical Experimentia, (Basel) 3: 371.
- 142 Rochae Silva M, Beraldo W. T, Rosenfeld G. 1949; Bradykinin, hypotensive and smooth muscle stimulator released from plasma globin by snake venoms and by trypsin. American Journal of Physiology 156: 261.
- 143 Ruddy S, Gigli I, Austen K. F. 1972; The complement system of man. New England Journal of Medicine 287: 545.
- 144 Saito H, Goldsmith G. Waldmann 1976; Fitzgerald factor (high molecular weight kininogen) clotting activity in human plasma in health and disease in various animal plasma. Blood 48: 941.
- 145 Saito H, Ratnoff O. D. 1974; Inhibition of normal clotting and Fletcher factor activity by rabbit anti-kallikrein antiserum. Nature 248: 597.
- 146 Saito H, Ratnoff R, Waldmann Abraham J. P. 1975; Fitzgerald trait. Deficiency of a hitherto unrecognized agent, Fitzgerald factor, participating in surface mediated reasctions of clotting, fibrinolysis, generation of kinins, and the property of diluted plasma enhancing vascular permeability (PF/dil). Journal of Clinical Investigation 55: 1082.
- 147 Sardesai V. M, Rosenberg J. C. 1974; Proteolysis and bradykinin turnover in endotoxin shock. Journal of Trauma 14: 945.
- 148 Schiffman S, Lee P. 1974; Preparation characterization, and activation of a highly purified factor XI: Evidence that a hitherto unrecognized plasma activity participates in the interaction of factors XI and XII. British Journal of Haematology 27: 101.
- 149 Schiffman S, Lee P. 1975; Partial purification and characterization of contact activation cofactor. Journal of Clinical Investigation 56: 1082.
- 150 Seki T, Makajime T, Erdos E. G. 1972; Colon kallikrein, its relation to the plasma enzyme. Biochemistry Pharmacology 21: 1227.
- 151 Sherry S, Alkjaersig N, Fletcher A. P. 1966; Observations on spontaneous arginine and lysine esterase activity of human plasma and their relation to Hageman factor. Thrombosis et Diathesis Haemorrhagica (Suppl.) 20: 243.
- 152 Sicuteri F, Antonini F. M, Delbianco P. L, Franchi G, Currodi C. 1972; Prekallikrein and kallikrein inhibitor in plasma of patients affected by recent myocardial infarction. Advances in Experimental Medicine and Biology 21: 445.
- 153 Sicuteri F, Delbianco P. L, Franciullacci M. 1970; Kinins in the pathogenesis of cardiogenic shock and pain. Advances in Experimental Medicine and Biology 9: 315.
- 154 Snyder A, Hand M. R, Gewenz H. 1974; A rapid pH state assay for plasma prekallikrein and fluctuations in disease. International Archives of Allergy 47: 400.
- 155 Soltay M. J, Movat H. Z, Ozge-Anwar A. H. 1971; The kinin system of human plasma V. The probable derivation of prekallikrein activator from activated Hageman factor (XIIa). Proceedings of the Society of Experimental Biology and Medicine 138: 952.
- 156 Soter N. A, Austen K. R, Gigli I. 1975; Inhibition by epsilon amino-caproic acid of the activation of the first component of the complement system. Journal of Immunology 114: 928.
- 157 Stewart D, Blendis I. M, Williams R. 1972; Studies on the prekallikrein-bradykinin system in liver disease. Journal of Clinical Pathology 25: 410.
- 158 Talamo R. C, Haber E, Austen K. F. 1969; A radioimmunoassay of bradykinin in plasma and synovial fluid. Journal of Laboratory and Clinical Medicine 74: 816.
- 159 Thune P, Ryan T. J, Powell S. M, Ellis R. J. 1976; The cutaneous reactions to kallikrein, prostaglandin and thurfyl nicotinate in chronic urticaria and the effect of polyphloretin phosphate. Acta Dermatology Benereol (Stockholm) 56: 217.
- 160 Van Arman C. G, Bohidar N. R. 1976 Role of the kallikrein kinin system in inflammation. In: Chemistry and Biology of the Kallikrein-kinin System in Health and Disease. Pisano J. J, Austen K. F. (ed.) 471.
- 161 Vassalio G, Solcia E, Cappella C. 1969; Light and electro microscopic identification of several types of endocrine cells in the gastrointestinal mucosa of the rat. Z Zellforsch 98: 333.
- 162 Veltkamp J. M, Demler H. C, Locliger E. A. 1965; Detection of heterozygotes for factor VIII, IX and XII deficiency. Thrombosis et Diathesis Haemorrhagica 13 (Suppl.) (17) 181.
- 163 Vennerod A. M, Laake K. 1976; Prekallikrein and plasminogen proactivator: Absence of plasminogen proactivator in Fletcher factor deficient plasma. Thrombosis Research 8: 519.
- 164 Wardle E. N, Piercy D. A. 1972; Studies of the contact activation in haemodialysis. Journal of Clinical Pathology 25: 1045.
- 165 Webster M. E, Guinaraes J. A, Kaplan A. P, Colman R. W, Pierce J. V. 1976. Activation of surface bound Hageman factor: Pre-eminent role of high molecular weight kininogen and evidence for a new factor. In: Kinins: Pharmacodynamics and biological roles. Sicuteri F, Back N, Haberland G. L. (eds.). Plenum Publishing Company; New York.:
- 166 Webster M. E, Pierce J. V. 1973; Activators of Hageman factor (Factor XII): Identification and relationship to kallikrein-kinin system. Federation Proceedings 32: 845.
- 167 Werle S, Vogel R, Kaliampetsos G. 1963 Über das Kallikrein der Darmwand und seine Beziehung zum Blutkallikreingehalt bei Störungen der Darmfunktion. In: Second Work Congress of Gastroenterology. (eds.). Schmid E, Tomenius J, Walkinson G, Basel S, Karger A. G. 788.
- 168 Wiegershausen B, Hennighausen G, Klausch B. 1970; Plasma kininogen levelin myocardial infarction. Advances in Experimental Medicine and Biology 8: 221.
- 169 Wong P. Y, Colman R. W, Talamo R. C, Babior B. M. 1972; Kallikrein-bradykinin system in chronic alcoholic liver disease. Annals of Internal Medicine 77: 205.
- 170 Wong P. Y, Talamo R. C, Babior B. M, Raymond G. G, Colman R. W. 1974; Kallikrein-kinin system is postgastrectomy dumping syndrome. Annals of Internal Medicine 80: 577.
- 171 Wong P. Y, Talamo R. C, Williams G. H, Colman R. W. 1975; Response of the kallikrein-kinin and renin-angiotensin systems to saline infusion and up-right posture. Journal of Clinical Investigation 55: 691.
- 172 Wong P. Y, Talamo R. C, Colman R. W, Williams G. H. 1976. Dependence of plasma bradykinin on state of sodium balance. In: Chemistry and Biology of Kallikrein-kinin System in Health and Disease. Pisano J. J, Austen K. F. (ed.). Fogarty International Center Proceedings no. 27 Washington, D.C: U.S. Government Printing Office; chapter 50 415.
- 173 Wong P. Y, Talamo R. C, Williams G. H. 1977 Kallikrein-kinin and renin-angiotensin systems in functional renal failure in cirrhosis of the liver. Gastroenterology. (in press).
- 174 Wuepper K. D. 1972. Biochemistry and biology of components of the plasma kinin-forming system. In: Inflammation: mechanisms and control. Lepow I. N, Ward P. A. (eds.) New York: Academic Press; 93.
- 175 Wuepper K. D. 1973; Prekallikrein deficiency in man. Journal of Experimental Medicine 138: 1345.
- 176 Zeitlin I. J. 1970. Kinin release associated with the gastrointestinal tract in bradykinin and related kinins. In: Sicuteri F, Rocha E. S, Back N. (eds.) New York: Plenum Press; 329.
- 177 Zeitlin I. J, Sharma J. N, Brooks P. M, Dick W. C. 1976. An effect of indomethacin on raised plasma kininogen levels in rheumatoid patients. In: Chemistry and Biology of the Kallikrein-kinin System in Health and Disease. Pisano J. J, Austen K. F. (eds.). DHEW; 483.
- 178 Zeitlin I. J, Singh Y. N, Lembeck R, Theiller M. 1976; The molecular weights of plasma and intestinal kallikreins in rats. Archives of Pharmacology 293: 159.
- 179 Zeitlin I. J, Smith A. N. 1966; 5-hydroxyindoles and kinins in the carcinoid and dumping syndrome. Lancet II: 986.